These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34478170)

  • 1. First case of DRESS (drug reaction with eosinophilia and systemic symptoms) associated with voxelotor.
    Lee M; Stringer T; Jacob J; Friedman EM; Minniti C; Billett HH; Curtis SA
    Am J Hematol; 2021 Nov; 96(11):E436-E439. PubMed ID: 34478170
    [No Abstract]   [Full Text] [Related]  

  • 2. Two drugs for sickle cell disease.
    Med Lett Drugs Ther; 2020 Apr; 62(1595):51-52. PubMed ID: 32324178
    [No Abstract]   [Full Text] [Related]  

  • 3. Two New Drugs for Sickle Cell Disease.
    Aschenbrenner DS
    Am J Nurs; 2020 Mar; 120(3):24. PubMed ID: 32079792
    [No Abstract]   [Full Text] [Related]  

  • 4. Voxelotor (GBT440), a first-in-class hemoglobin oxygen-affinity modulator, has promising and reassuring preclinical and clinical data.
    Estepp JH
    Am J Hematol; 2018 Mar; 93(3):326-329. PubMed ID: 29352729
    [No Abstract]   [Full Text] [Related]  

  • 5. Voxelotor: A Novel Treatment for Sickle Cell Disease.
    Herity LB; Vaughan DM; Rodriguez LR; Lowe DK
    Ann Pharmacother; 2021 Feb; 55(2):240-245. PubMed ID: 32674605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Voxelotor: A First-in-Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease.
    Han J; Saraf SL; Gordeuk VR
    Pharmacotherapy; 2020 Jun; 40(6):525-534. PubMed ID: 32343424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).
    Silva SA; Figueiredo MM; Carneiro L; Reiss DB; Damásio MA
    Rev Assoc Med Bras (1992); 2016; 62(3):227-30. PubMed ID: 27310545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of drug reaction with eosinophilia and systemic symptoms (DRESS) without a typical precipitant.
    Griffin DW; Martin GE; McLean C; Cheng AC; Giles ML
    Med J Aust; 2020 Apr; 212(7):300-301.e1. PubMed ID: 32092152
    [No Abstract]   [Full Text] [Related]  

  • 10. Voxelotor use in adults with sickle cell disease in a real-world setting.
    Curtis SA; Betancourt J; Kottapalli N; Campbell S; Minniti C
    Am J Hematol; 2022 Mar; 97(3):E125-E128. PubMed ID: 34967959
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
    Hebbel RP; Hedlund BE
    Am J Hematol; 2018 Mar; 93(3):321-325. PubMed ID: 29150874
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with failure to respond to cyclosporine treatment.
    Clark D; Alomari AK; Burton K; Rahnama-Moghadam S
    Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms syndrome induced by apixaban.
    Menteşoğlu D; Doğan Günaydın S; Ersoy-Evans S
    Dermatol Ther; 2020 Jul; 33(4):e13719. PubMed ID: 32472629
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report.
    Myers CM; Miller JJ; Davis WD
    Adv Emerg Nurs J; 2020; 42(2):108-118. PubMed ID: 32358426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic findings in drug reaction with eosinophilia and systemic symptoms (DRESS).
    Pukhalskaya T; El Hussein S
    Am J Hematol; 2021 Nov; 96(11):1548-1550. PubMed ID: 34486770
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Reaction, Eosinophilia, and Systemic Symptoms (DRESS) syndrome associated with allopurinol leading to acute necrotizing eosinophilic myocarditis and death due to papillary muscle rupture.
    Menter T; Tzankov A
    J Allergy Clin Immunol Pract; 2016; 4(6):1262-1264. PubMed ID: 27523276
    [No Abstract]   [Full Text] [Related]  

  • 17. Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome.
    Mirza S; Hill E; Ludlow SP; Nanjappa S
    Melanoma Res; 2017 Jun; 27(3):271-273. PubMed ID: 28146044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS).
    Chou HY; Chen CB; Cheng CY; Chen YA; Ng CY; Kuo KL; Chen WL; Chen CH
    J Clin Pharm Ther; 2015 Dec; 40(6):689-92. PubMed ID: 26365588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS).
    Hoshina D; Furuya K; Okita I
    Clin Exp Dermatol; 2015 Jun; 40(4):455-6. PubMed ID: 25545118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.